CREB3L2 and Familial prostate cancer: Notably, BRAF and CREB3L2 are both in the KEGG pathway for prostate cancer, thus raising the possibility that PLX4720 may also play a role in interfering with CREB3L2 binding to DNA and impacting transcription, possibly in prostate cancer.